Comparing Corilagin with Paclitaxel, a known chemotherapeutic drug for ovarian cancer, Corilagin inhibited both cell growth and the secretion of TGF-β1, while Paclitaxel only inhibited cell growth (Figure 6B, C). Here, TGFB1 is linked to ovarian cancer.